A comprehensive eight-year study examining audiological outcomes of newborns screened for congenital cytomegalovirus (cCMV) ...

Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today announced that the U.S. Food and Drug Administration (FDA) ...

Takeda (TSE:4502/NYSE:TAK) announced the completion of the 7-year pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial evaluating its dengue vaccine, QDENGA®?(Dengue ...

Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

Detailed price information for Os Therapies Incorporated (OSTX-A) from The Globe and Mail including charting and trades.

HealthDay News — Recommendations have been developed for management of pediatric patients with tracheostomies and published in a clinical practice guideline from the American Thoracic Society ...

A 6-year-old boy presents to the emergency department after a motor vehicle collision at 90 km/h. The child was properly restrained, had no loss of consciousness, and experienced 1 episode of emesis ...

INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...

Kubota, C. (2025) The Utility of Offering Course Subjects on Family Support for Paramedics in an Undergraduate Curriculum.

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter of 2025 and the completion of ESSENCE, its global, Phase ...

Jessica Osman, D.O., UPMC Pediatrics in North Central Pa., has been honored with the UPMC Excellence in Patient Experience ...